The potential use of ebselen in treatment-resistant depression
Ebselen is an organoselenium compound developed as an antioxidant and subsequently shown to be a glutathione peroxidase (GPx) mimetic. Ebselen shows some efficacy in post-stroke neuroprotection and is currently in trial for the treatment and prevention of hearing loss, Meniere’s Disease and severe a...
Huvudupphovsmän: | Ramli, FF, Cowen, PJ, Godlewska, BR |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
MDPI
2022
|
Liknande verk
-
The Potential Use of Ebselen in Treatment-Resistant Depression
av: Fitri Fareez Ramli, et al.
Publicerad: (2022-04-01) -
Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
av: Ramli, FF, et al.
Publicerad: (2024) -
Investigating the effects of the lithium-mimetic drug, ebselen, on emotional processing and brain neurochemistry in patients with medication-resistant depression
av: Ramli, FF
Publicerad: (2024) -
Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing
av: Masaki, C, et al.
Publicerad: (2016) -
Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
av: Fitri Fareez Ramli, et al.
Publicerad: (2024-05-01)